Evidence map›Paper›PMID 34729077›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Yanchun Pu, Ping Jin, Lianghong Liu, Qinlin Pu, Fangping Wu

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Retracted:Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
4 · The record

Corrections and comments

  • Retraction · 2023-12-13Compromised Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Unreliable Results and/or Conclusions ·
  • Retracted
5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yanchun PuSchool of Pharmaceutical Sciences, Hunan University of Medicine, No. 492, Jinxi South Road, Huaihua, Hunan Province 418099, China.
Ping JinSchool of Pharmaceutical Sciences, Hunan University of Medicine, No. 492, Jinxi South Road, Huaihua, Hunan Province 418099, China.
Lianghong LiuSchool of Pharmaceutical Sciences, Hunan University of Medicine, No. 492, Jinxi South Road, Huaihua, Hunan Province 418099, China.
Qinlin PuSchool of Pharmaceutical Sciences, Hunan University of Medicine, No. 492, Jinxi South Road, Huaihua, Hunan Province 418099, China.
Fangping WuSchool of Pharmaceutical Sciences, Hunan University of Medicine, No. 492, Jinxi South Road, Huaihua, Hunan Province 418099, China.ORCID https://orcid.org/0000-0002-6913-1864
Hunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study, we aim to investigate the effect of

methodsA total of 30 BALB/C nude mice (class SPF) were equally and randomly divided into the control group, model group, and

resultsThe tumorigenesis rates of the control group, model group, and

conclusionPodophyllotoxin in

Identifiers

PMID34729077
PMCPMC8557981
OpenAlexW3204978909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.